Sommaire

Numéro précédent | Numéro suivant

• • ·SIU meeting on prostatic disease : Bariloche, Argentina, Sept. 29-Oct. 1, 2005 Scientific Programme

    Page :A4

    Plan Plan
• • ·Elevated prostate specific antigen density (PSAD) estimation is more useful in predicting cancer when gland volume is between 61–90 cc on transrectal ultrasound

    Page :1

    K. Loughlin, J. Lewis

    Plan Plan
• • ·Can PSA patterns prior to prostate biopsy predict prostate cancer?

    Page :1-2

    D. Connolly, T. Nambirajan, L.J. Murray, A. Gavin, P.F. Keane

    Plan Plan
• • ·TRUS biopsy for suspected prostate cancer; how reassuring is a negative result?

    Page :2

    M. Speakman, M. Harris

    Plan Plan
• • ·Extended prostate needle biopsy with ten cores. Concordance grading between prostate needle biopsy and radical prostatectomy

    Page :2-3

    F. Gomez Veiga, J. Ponce, A. Barbagelata, E. Romero, S. Pertega, E. Rosado, M. Ruibal, L.A. Castelo, M. Gonzalez Martin

    Plan Plan
• • ·Intrarectal cooled lignocaine gel for pain control during transrectal prostate biopsy

    Page :3

    A.İ. Oǧuzülgen, M.İ. Tekin, H. Özkardeş

    Plan Plan
• • ·Real-time tissue elasticity imaging (Elastography) for prostate cancer detection

    Page :3

    M. Tsutsumi, T. Miyakawa, S. Ishikawa, T. Matsumura, T. Shiina, N. Miyanaga, H. Akaza

    Plan Plan
• • ·APTIMA® PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer

    Page :3-4

    C. Giachetti, J. Groskopf, S. Walker, I. Deras, C. Clark, S. Bodrug, A. Blase, S. Brentano, H. Rittenhouse, M. Desaulniers, C. Chypre, Y. Fradet

    Plan Plan
• • ·Toremifene for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer: phase II results and phase III design

    Page :4

    E. Harrison, M. Steiner, K.G. Barnette

    Plan Plan
• • ·Androgen deprivation therapy as primary treatment for clinically localized prostate cancer: data from CaPSURE

    Page :4

    J. Kawakami, J. Cowan, E.P. Elkin, D.M. Latini, J. DuChane, P.R. Carroll, CaPSURE Investigators 2

    Plan Plan
• • ·A comparison of docetaxel monotherapy given weekly or every 3 weeks in patients with hormone refractory prostate cancer (HRCaP)

    Page :4-5

    R. Sood, V. Jain, D. Chauhan

    Plan Plan
• • ·International study into the use of intermittent therapy in prostate cancer

    Page :5

    G. Shaw, L. Cotton, P. Wilson, J. Cuzick, R.T.D. Oliver

    Plan Plan
• • ·Prostate brachytherapy. Complications, prognostic factors, and results

    Page :5-6

    A. Rempelakos, A. Palanzas, G. Kritselis, A. Papas, G. Ioanidou, A. Thanos

    Plan Plan
• • ·Iodine 125 brachytherapy for favorable risk prostate cancer: results for 509 patients. When can we start to trust PSA after brachytherapy?

    Page :6

    J. Crook, I. Yeung, C. Gillan, M. McLean, G. Lockwood

    Plan Plan
• • ·Treatment of intermediate or high-risk prostate cancer by dose escalation with HDR brachytherapy: early toxicity and biochemical outcome of two treatment regimens

    Page :6-7

    B. Guix, R. Serrate, I. Henrı́quez, J.M. Bartrina, J.R. Vendrell, J.I. Tello

    Plan Plan
• • ·Comparison of pre-implant prostate volume with intra-operative volume in patients undergoing prostate brachytherapy

    Page :7

    H.U. Ahmed, K. Pigott, A.V. Kaisary

    Plan Plan
• • ·Treatment of early prostate cancer using high dose rate brachytherapy in combination with external beam radiation

    Page :7

    P. Gilson, A. Razek, A. Korba, S. Shah, P. Siami, B. Romick, B. Samm, T. Gadient, A. Sorensen, B. Smith, W. Fisher, D. Foertsch

    Plan Plan
• • ·Nerve-sparing radical perineal prostatectomy using Ultracision® and Cavermap®: a preliminary report

    Page :7-8

    E. Austoni, I. Kartalas-Goumas

    Plan Plan
• • ·Radical prostatectomy — extraperitoneal laparoscopic approach as standard procedure with a steep training curve. Experiences from 220 cases between August 2003 and March 2005

    Page :8

    W. Wagner, J. Westphal, P. Anheuser, A. Rauch

    Plan Plan
• • ·Quality assurance in urologic oncology: a radical prostatectomy experience of 2254 cases

    Page :8

    J. Montie, J. Wei, D. Miller, R. Dunn

    Plan Plan
• • ·Radical prostatectomy: retropubic (RRP) vs. laparoscopic (RLP) vs. perineal (RPP) vs. robotic (RAP)

    Page :8

    E. Castle, F. Atug, S. Burgess, F. Mendez-Torres, R. Davis, R. Thomas

    Plan Plan
• • ·Laparoscopic radical prostatectomy: our experience of 180 operations

    Page :9

    Y. Wang, M. Waldén

    Plan Plan
• • ·Experience of endoscopic minilaparotomy radical prostatectomy

    Page :9

    Y. Kamiryo, N. Yamamoto, T. Moriwaka

    Plan Plan
• • ·The use of water jet dissection for nerve sparing radical prostatectomy

    Page :9

    J. Djozic, J. Bogdanovic, M. Popov

    Plan Plan
• • ·Comparación del tiempo quirúrgico en la prostatectomı́a radical entre la sutura tradicional y Capio^® RP suturing device ası́ como de sus respectivas complicaciones

    Page :10

    J.J. Lobato, C. Giner, A. Leivar, J.P. Caballero, L. Pérez-Llorca, J. Jiménez

    Plan Plan
• • ·Adenocarcinoma mucinoso en resección prostática

    Page :10

    R. Sanchez Marull, A. San Roman, F. Paesano, J. Echaburu

    Plan Plan
• • ·High intensity focused ultrasound (HIFU) for PCa: 4 years - 350 patients - Ablatherm - AZ Middelheim, Antwerp, Belgium

    Page :10-11

    C. D’Hont, P. Van Erps, J. Cortvriend, M. Sorber

    Plan Plan
• • ·High-intensity focused ultrasound for the treatment of low-risk organ confined prostate cancer: Initial experience from a single UK centre

    Page :11

    J. Kennedy, T. Leslie, S.F. Brewster, M. Sullivan

    Plan Plan
• • ·Ultrasonido de alta intensidad en el tratamiento del adenocarcinoma prostatico localizado en el paciente con trasplante renal o pre-trasplante

    Page :11

    E. Lledo-Garcia, J. Jara-Rascon, G. Pedemonte, F. Anaya Fernandez De Lomana, C. Hernandez Fernandez

    Plan Plan
• • ·Unified theory of prostate cancer: the role of steroid 5 alpha reductase and steroid aromatase

    Page :11-12

    W. Pitts, D. Scherr

    Plan Plan
• • ·Protein kinase C and COX-2 expression in androgen sensitive and androgen independent prostate cancer

    Page :12

    S.N. Nalagatla, J. Edwards, M. Underwood, J.M.S. Bartlett

    Plan Plan
• • ·The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography in prostate cancer

    Page :12

    M. Tsugaya, M. Iwase, T. Ito, S. Okada, S. Endo, M. Nishio, T. Tamaki, K. Kawahara

    Plan Plan
• • ·Hereditary prostate cancer

    Page :12-13

    A.V. Bono

    Plan Plan
• • ·Effect of diet and nutrition on prostate cancer

    Page :13

    R. Wheeler

    Plan Plan
• • ·Gastrointestinal stromal tumor (GIST) presenting as a prostate tumor

    Page :13

    D. Sandblom, J. Rutegard, F. Dahl, B. Ehrnstrom, M. Carringer

    Plan Plan
• • ·Relationship between prostate cancer and serum dyslipidemia

    Page :13-14

    R. Gillitzer, S. Pahernik, C. Hampel, S. Petry, S.W. Melchior, J.W. Thüroff

    Plan Plan
• • ·Prospective evaluation of the difference in core and surface temperature, severity of symptoms and prevalence of hot flushes after bilateral orchidectomy for prostate cancer

    Page :14

    N.A. Aziz, C.F. Heyns

    Plan Plan
• • ·The effects of changes in testosterone level on the development of prostate cancer

    Page :14-15

    A. Pechersky, V. Semiglazov, O. Loran, V. Mazurov, A. Karpischenko, A. Nikiforov, N. Kalinina, L. Drygina, N. Davydova, M. Skorobogatikh

    Plan Plan
• • ·Hyperbaric oxygen for the treatment of radiation morbidity in prostate cancer: long term results

    Page :15

    R. Mayer, H. Klemen, F. Quehenbrger, O. Sankin, S. Gabor, F. Smolle-Juettner

    Plan Plan
• • ·Principles of anatomy for male transobturator perineal suspension for the treatment of post-prostatectomy incontinence

    Page :15

    Gozzi Christian, Peter Rehder

    Plan Plan
• • ·Laparoscopic radical prostatectomy: perioperative and functional outcomes in an HMO setting

    Page :15

    M. Choi, G. Bellman

    Plan Plan
• • ·The prevalence of prostate cancer at different levels of PSA and PSA ratios. A study on 400 consecutive patients who underwent ultrasound guided core needle biopsies

    Page :16

    L. Rydén, P. Ekman, L. Egevad, M. Hellstrüm

    Plan Plan
• • ·Tratamiento con braquiterapia I125 del carcinoma de próstata órganoconfinado de bajo riesgo

    Page :16

    J.F. Suárez Novo, F. Aguiló Lucia, S. Pastor Loópez, E. Condom Mundo, J. Pera Fabregas, R. Correa Generoso

    Plan Plan
• • ·Photoselective vaporization of the prostate (PVP): feasibility and safety as an office based modality

    Page :17

    M. Hai

    Plan Plan
• • ·Factors influencing efficacy outcomes in photoselective vaporization prostatectomy (PVP): results and analysis of ongoing prospective multicenter study at 3 years

    Page :17-18

    B.S. Stein, A.E. Te, T.R. Malloy, J.C. Ulchaker, U.O. Nseyo, M.A. Hai

    Plan Plan
• • ·Green light KTP laser vaporisation prostatectomy in patients receiving anti-thrombotic medications

    Page :18

    A. Kaisary

    Plan Plan
• • ·Same-session KTP laser vaporization of large prostate and holmium laser treatment of bladder stones

    Page :18

    S. Thomas Sadio, B. Eisner, S. Tabatabaei

    Plan Plan
• • ·Photoselective KTP laser vaporization of the prostate in men with large prostates

    Page :19

    B. Eisner, S. Tabatabaei

    Plan Plan
• • ·High-power KTP photoselective laser vaporization prostatectomy: the New York Presbyterian experience

    Page :19

    B. Reddy, R.R. Gonzalez, J.S. Sandhu, S.A. Kaplan, A.E. Te

    Plan Plan
• • ·Prostate ethanol chemoablation for BPH

    Page :19-20

    S.E. Faur, D.M. Surur, E.S. Staneloni, G. Martín Del Sordo, G. Stoliar, G.L. Garrido, O.N. Mazza

    Plan Plan
• • ·Transurethral photodynamic therapy (PDT) with lemuteporfin in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH): initial clinical experience

    Page :20

    R. Perez-Marrero, S. Goldenberg, N. Shore, E. Benaim, R. Fay, M. Manyak, M. Elhilali

    Plan Plan
• • ·Holmium laser enucleation of the prostate (HoLEP): a size independent new gold standard

    Page :20

    E. Elzayat, E. Habib, M. Elhilali

    Plan Plan
• • ·Transurethral chemical injection for the treatment of BPH

    Page :20

    R.F. Labayen

    Plan Plan
• • ·Phase I study of a methanol extract of Ganoderma lucidum, edible and medicinal mushroom, in men with mild symptoms of bladder outlet obstruction

    Page :21

    M. Noguchi, T. Kakuma, K. Tomiyasu, F. Konishi, S. Kumamoto, R. Kondo, K. Matsuoka

    Plan Plan
• • ·Comparative study of phytotherapy vs. alpha blockers in BPH virgo patient

    Page :21

    Z. Leib, Y. Dekel, J. Sulkes, J. Baniel, P.M. Livne

    Plan Plan
• • ·Effects of prostatic calculi removal…

    Page :21

    
• • ·Sexual dysfunction and its impact on quality of life in patients with lower urinary tract symptoms (LUTS)

    Page :21-22

    G. Rosta, Z. Kopa, J. Bakai, K. Erdei, G. Papp, K. Sandori

    Plan Plan
• • ·Postoperative serum prostate specific antigen levels in patients undergoing surgical treatment for benign prostatic obstruction

    Page :22

    A. Dirim, K. Öztürk, A.İ. Oǧuzülgen, M.İ. Tekin, H. Özkardeş

    Plan Plan
• • ·Urinary retention following arthroplasty

    Page :22

    P. Kumar, K. Mannan, A. Chowdhury, K. Kong, J. Pati

    Plan Plan
• • ·Radiogenic pathophysiological reactions in the urogenital system (UGS)

    Page :22-23

    E. Neu, M. Michailov, J. Hess, C. Reiser, J. Foltinova

    Plan Plan
• • ·Cooled thermotherapy (TUMT) for chronic abacterial prostatitis (CP/CPPS): 2 years after treatment

    Page :23

    P.D. Miller, C. Kastner, H. Fletcher, C. Nelson, M.C. Jennings

    Plan Plan
• • ·Persisting lower urinary symptoms of chronic prostatitis

    Page :23

    R. Amdiy, S.H. Al-Shukri

    Plan Plan
• • ·Author index

    Page :25-26